|
The Distinguished Alumnus
Award is presented to a graduate who has achieved special
recognition in his or her professional career. We are proud this
year to honor:
Robert G.
Urban, Ph.D., was named Distinguished Alumnus of the Graduate
School of Biomedical Sciences at the May 2004 commencement
ceremonies.
Dr.
Urban is a 1986 graduate of the University of Texas where he
received his B.A. in microbiology. He earned his Ph.D. in
microbiology and immunology from UTMB in 1991, and continued his
training at Harvard University with a five-year fellowship in
structural immunology.
From
1992 to 1995 Dr. Urban was founder and president of Tomorrow’s
Technologies, a biotech consulting practice. His next venture
was as scientific co-founder of ZYCOS, Inc. (formerly known as
PANGAEA Pharmaceutical). ZYCOS, Inc., is a privately held drug
development company based in Lexington, Mass. Since its
inception in 1996, the Company has generated a series of
distinct new medical entities and conducted multiple clinical
trials in treatments for chronic viral diseases and cancer.
For the past 10 years,
Dr. Urban has provided key leadership for ZYCOS, Inc., serving
as Director of Infectious and Oncologic Disease, Vice President
for New Technologies and Targets, and currently as Vice
President for corporate development. ZYCOS, Inc. is a drug
development company focused on converting genetic information
into novel therapeutics.
Dr. Urban
co-invented the BIOTOPE therapeutic system and CANVAS discovery
platform. He has overseen external collaborations, evaluations
and in-house licensing of technologies for ZYCOS. |
